The American Association of Pharmaceutical Scientists (AAPS) and the International Pharmaceutical Federation (FIP) presented the following researchers with prestigious awards for their contributions to pharmaceutical sciences: Ho-Leung Fung, Dale E. Wurster, Michael G. Bartlett, Peter A. Crooks, Abu T.M. Serajuddin, Meindert Danhof, Sa...
The American Association of Pharmaceutical Scientists (AAPS) presented several awards to researchers and students for their contributions to the pharmaceutical sciences. The awards included AAPS Presidential Citation, Dr. Rainer Hoffman Product through Science Award, and AAPS Community Service Award among others.
The American Association of Pharmaceutical Scientists (AAPS) honored outstanding researchers with awards for their contributions to biotechnology. The Excellence in Ligand-Binding Assay Award and Innovation in Biotechnology Awards recognized achievements in fields such as drug detection, vaccine development, and cancer treatment.
Novel vaccines targeting immune cells in the gut may improve patient compliance and vaccination rates, especially in developing countries. Powder-based vaccinations also show promise, with stable dry powder formulations stabilizing the TB vaccine.
Researchers have discovered high-activity mutants of human butyrylcholinesterase that could be used to develop anti-cocaine medication. Additionally, a microbiocide-based HIV prevention measure holds promise for developing countries, particularly in sub-Saharan Africa.
Researchers have developed tumor-penetrating microparticles (TPM) to deliver drugs more effectively, targeting both rapid- and slow-growing tumors. TPM has shown promise in treating pancreatic cancer by breaking through barriers and delivering highly concentrated drug doses.
Researchers developed an optimized mouthpiece design to reduce medication waste and improve drug delivery to the lungs. The new design allows for more medication to pass through the mouthpiece, ensuring effective delivery of future inhaled medications.
A new method of delivering measles vaccines, using an inhalable powder, has shown promise in test animals. The powder is produced by mixing a weakened measles virus with high-pressure carbon dioxide and can remain stable for at least eight weeks at room temperature.
Researchers have developed a new vaginal device that delivers at least 10 times more medication to the uterus than existing oral medications, reducing side effects and potentially alleviating menstrual cramp pain. Phase II clinical trials will assess efficacy of the treatment in reducing pain.
A new oral formulation of vitamin B12 has shown promise in improving absorption rates without the need for invasive injections. The eligen technology has been tested in animal studies and is currently being conducted in human trials.
The book examines key issues in dietary supplements, including shelf life testing, regulatory implications, and standardizing botanical extracts. Experts address the need for critical pre-purchase research to protect consumers from potentially dangerous or ineffective products.
The AAPS PharmSci theme issue delves into the current status of personalized medicine and its promises and limitations. The issue explores new technologies, genetic testing, and individualized approaches to drug therapy.
The American Association of Pharmaceutical Scientists (AAPS) is hosting a workshop on bioanalytical methods validation, which aims to review progress since the first workshop in 1989. The event will focus on identifying and resolving scientific issues related to quantitative bioanalytical methodology.
The AAPS Annual Meeting highlights the growing burden of non-communicable diseases, with new treatments offering hope for patients. The meeting showcases innovative therapies, including an inhalable flu vaccine and a new AIDS medication regimen.
The PQRI Workshop on Blend Uniformity brings together industry, academia, and government to discuss batch homogeneity issues and identify scientific and regulatory gaps. The workshop aims to provide preliminary recommendations for science-based changes to guidelines and regulations.
The AAPS Workshop on Biopharmaceutics in the New Millennium will discuss new scientific approaches to measure bioavailability (BA) and document bioequivalence (BE) for orally administered drug products. The workshop will also explore challenges and propose approaches for harmonizing international regulatory guidances.
The article describes how novel human genes can be found using data mining techniques on the Internet. Researchers identified putative human genes related to peptide transporter proteins, which are essential for drug absorption and distribution.
The AAPS Workshop on Analytical Methods Post Approval Changes and Packaging Post Approval Changes brings together experts to discuss scientific issues related to post-approval changes. Speakers will explore viable approaches to predict the impact of these changes on drug quality.
The journal features novel approaches to analyzing complex peptides, such as pramlintide, and developing injectable implants for sustained drug release. Liposomes are also explored as carriers for antimicrobial peptides like Leucinostatin A.
Researchers developed an interactive 3D molecular model of GRK2, a crucial regulator of neurotransmitter and hormone receptors. The model allowed scientists to interact with the molecular structure, facilitating the identification of new lead compounds as inhibitors of GRK2.
The AAPS Workshop on Bioanalytical Methods Validation (BMV) for Macromolecules aims to determine industry standards and validation considerations for quantitative macromolecule-detecting technologies. The workshop will develop a report on bioanalytical validation criteria and standardization of terminology.
The American Association of Pharmaceutical Scientists (AAPS) has released new research on the influence of direct-to-consumer advertising (DTCA) on doctors' prescribing habits. A study found that half of physicians feel pressure to prescribe products patients have seen advertised, with 77% linking patient requests to TV advertising. Ad...
The American Association of Pharmaceutical Scientists (AAPS) has selected ten individuals for its prestigious Fellow status in recognition of their significant contributions to the field of pharmaceutical sciences. The new AAPS Fellows include experts from academia, industry, and government institutions worldwide.
The American Association of Pharmaceutical Scientists (AAPS) recognizes outstanding researchers with its annual awards. Joseph R. Robinson receives the Distinguished Pharmaceutical Scientist Award for his work on controlled drug delivery and ocular drug disposition, while Charles Russell Middaugh wins the Research Achievement Award in ...
The American Association of Pharmaceutical Scientists has premiered an online database of the abstracts to be presented at the upcoming annual meeting. The database includes all invited and contributed paper abstracts, with a unique personal itinerary feature allowing attendees to plan their meetings.
Researchers at the University of Utah have discovered a naturally-occurring antibody that significantly reduces diabetic symptoms in mice. The study's findings suggest that masking the foreign nature of affected cells may prevent immunological processes that cause diabetes. Eighty percent of treated mice did not develop diabetic symptoms.
The AAPS International Workshop on Individual Bioequivalence aims to review available criteria, discuss their pros and cons, and explore various points in drug development and approval. The workshop will focus on evidence for/against a Subject by Formulation interaction, statistical issues, and FDA strategy.
The AAPS Workshop on Regulatory Issues Related to Drug Products for Oral Inhalation and Nasal Delivery will focus on quality assurance, CMC data, and bioavailability. The workshop aims to advance science through open exchange of knowledge and contribute to human health through pharmaceutical research.
A new study from UCSF found that grapefruit juice can inhibit the body's absorption of certain drugs, including cancer medication Vinblastine and HIV protease inhibitor saquinavir. Patients taking these medications with grapefruit juice may experience increased levels of the drug in their blood.
The American Association of Pharmaceutical Scientists has recognized eight researchers with awards for their outstanding contributions to the field. Sung Wan Kim received the AAPS-Dale E. Wurster Research Award in Pharmaceutics for his work on controlled drug delivery systems, while Vincent H.L. Lee was honored with the Distinguished S...
The American Association of Pharmaceutical Scientists (AAPS) Annual Meeting will focus on key topics such as emerging trends in drug design and development. Recent research also highlights the risks of sound-alike drugs causing prescription errors and the impact of high altitudes on drug efficacy.
The American Association of Pharmaceutical Scientists (AAPS) has launched an online database of 2200+ abstracts from its 1998 Annual Meeting. The fully searchable database allows attendees to build a personalized itinerary for the meeting and plan which presentations to attend. Additionally, AAPS PharmSci will release online, print and...
The AAPS is co-sponsoring the FDA Science Forum, bringing together experts in bioengineering, diagnostics, and regulatory science to discuss the impact of biotechnology on product development and regulation. The forum will cover topics such as gene therapy, cell and tissue engineering, and vaccine development.